MeSH tree: A11.329
Most cancer deaths are not caused by the original tumor, but by metastases, which form when cancer cells leave the original tumor and spread to other organs. To do so, cancer cells must loosen their attachment to other cancer ...
4 hours ago
0
6
A new study from Mayo Clinic suggests checkpoint immunotherapy may reshape the immune environment within lymph nodes after melanoma has spread to them. Researchers found that treatment reorganized several types of immune ...
Oct 30, 2026
0
59
Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular ...
Oct 30, 2026
0
484
Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, along with researchers at Dana-Farber Cancer Institute and the Broad Institute, have uncovered biological clues to why colorectal ...
Oct 29, 2026
0
298
Sustained low-level inflammation is a hallmark of the aging process. The accumulating damage persistently activates the innate immune system—the body's first line of defense—leading to what is known as inflammaging, functional ...
Oct 28, 2026
0
1247
One person dies every 50 seconds in the U.S. from cancer, and an estimated 39% of people in the country will develop cancer during their lifetime. Survival rates have improved in recent decades from innovations and combinations ...
Oct 28, 2026
0
7
Obesity touches countless lives across the country and can lead to many other health complications. From August 2021 to 2023, the prevalence of obesity in adults in the U.S. was more than 40%. Research published in Science ...
Oct 27, 2026
0
21
Researchers at LSU's Pennington Biomedical Research Center have developed and validated a new genetic animal model that gives scientists a more precise way to study brown and beige fat, specialized tissues that use energy ...
Oct 25, 2026
0
26
Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is the dense tissue surrounding the tumor that acts as a protective barrier and suppresses the immune ...
Oct 23, 2026
0
113
A team led by Harvard Medical School researchers at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute has developed a faster way to identify and engineer cancer-fighting therapies.
Oct 15, 2026
0
10
